State of Wisconsin Investment Board’s AEON Biopharma AEON Stock Holding History

State of Wisconsin Investment Board’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,985	Closed	-$2.89M	–	2543
2022 Q4	$2.89M	Hold	3,985	–	–	0.01%	1206
2022 Q3	$2.83M	Hold	3,985	–	–	0.01%	1220
2022 Q2	$2.81M	Hold	3,985	–	–	0.01%	1270
2022 Q1	$2.81M	Buy	3,985 +513	+15%	+$360K	0.01%	1391
2021 Q4	$2.43M	Buy	3,472 +1,250	+56%	+$879K	﹤0.01%	1228
2021 Q3	$1.56M	Buy	+2,222	New	+$1.55M	﹤0.01%	1339

Other funds holding AEON

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

GCWM

Graham Capital Wealth Management Washington D.c., District of Columbia $129M AUM 16.02% 1-Year Est. Return

State of Wisconsin Investment Board's AEON Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 3,985 shares — an estimated $2.89M sold.

State of Wisconsin Investment Board first reported a position in AEON in Q3 2021 and held it in 6 quarters. The position peaked at $2.89M in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

State of Wisconsin Investment Board reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
State of Wisconsin Investment Board sold 3,985 AEON Biopharma shares in Q1 2023, an estimated $2.89M.
State of Wisconsin Investment Board first reported a position in AEON Biopharma in Q3 2021 and held it in 6 quarters.
State of Wisconsin Investment Board's AEON Biopharma position peaked at $2.89M in Q4 2022.
21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.